Clinical Trial

Effect of Consuming a Mango and Chia-based Beverage on Modulating the Intestinal Microbiota in Obese Children

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 14, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized clinical trial evaluates the effect of a mango and chia-based beverage on gut microbiota modulation in 100 Paraguayan children aged 8-16 years with obesity. Participants will consume the intervention beverage for 6 weeks. Fecal samples will be collected before and after each intervention to analyze microbiota composition using 16S rRNA sequencing. This study aims to characterize the gut microbiota of Paraguayan children for the first time and assess whether this functional beverage can positively modulate intestinal bacteria as a potential strategy to address childhood obesity, which affects 1 in 3 school-age children in Paraguay.
Trial Details
NCT Number NCT07529119
Lead Sponsor Universidad Nacional de Caaguazu
Conditions Microbiota
Enrollment 100 participants
Start Date 2026-02-09
Primary Completion 2026-05 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-04-14